Katerva Chooses Draper Antiviral Therapy As Finalist for...

Katerva has chosen Draper Laboratory’s DRACO antiviral therapy as a finalist for its 2013 award in the Human Development category. All of the finalists for the 2013 Katerva Award, which is billed as...(PRWeb March 13, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11647144.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news